Murat Gokden
Concepts (327)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Brain Neoplasms | 14 | 2024 | 284 | 2.670 |
Why?
| Neurodegenerative Diseases | 2 | 2024 | 83 | 1.520 |
Why?
| Pituitary Neoplasms | 3 | 2021 | 27 | 1.180 |
Why?
| Adenoma | 3 | 2021 | 142 | 1.050 |
Why?
| Carcinoma, Renal Cell | 5 | 2010 | 119 | 0.940 |
Why?
| Immunohistochemistry | 17 | 2022 | 1097 | 0.890 |
Why?
| Alzheimer Disease | 2 | 2024 | 365 | 0.830 |
Why?
| Brain | 6 | 2024 | 1364 | 0.810 |
Why?
| Central Nervous System | 2 | 2022 | 85 | 0.780 |
Why?
| Proto-Oncogene Proteins c-bcl-6 | 1 | 2020 | 9 | 0.770 |
Why?
| Dementia, Vascular | 1 | 2020 | 6 | 0.760 |
Why?
| Pathology, Surgical | 1 | 2020 | 27 | 0.750 |
Why?
| Genes, myc | 1 | 2020 | 47 | 0.750 |
Why?
| Lymphoma, Large B-Cell, Diffuse | 2 | 2020 | 97 | 0.750 |
Why?
| Biological Specimen Banks | 1 | 2020 | 22 | 0.750 |
Why?
| Glioblastoma | 2 | 2021 | 99 | 0.740 |
Why?
| Nervous System Diseases | 1 | 2021 | 97 | 0.720 |
Why?
| Amyloidosis | 1 | 2020 | 85 | 0.720 |
Why?
| Kidney Neoplasms | 4 | 2010 | 195 | 0.690 |
Why?
| Cytochrome-c Oxidase Deficiency | 1 | 2018 | 9 | 0.680 |
Why?
| Electron Transport Complex IV | 1 | 2018 | 49 | 0.670 |
Why?
| Optic Atrophy | 1 | 2018 | 18 | 0.660 |
Why?
| Carcinoma, Papillary | 3 | 2015 | 65 | 0.660 |
Why?
| Leukemia, Lymphoid | 1 | 2018 | 6 | 0.660 |
Why?
| Brain Edema | 1 | 2018 | 39 | 0.660 |
Why?
| Spasms, Infantile | 1 | 2018 | 30 | 0.650 |
Why?
| Humans | 62 | 2024 | 54132 | 0.650 |
Why?
| Intracranial Embolism | 1 | 2018 | 28 | 0.650 |
Why?
| Solitary Fibrous Tumors | 1 | 2017 | 5 | 0.600 |
Why?
| Spinal Cord Neoplasms | 1 | 2017 | 15 | 0.600 |
Why?
| Meningeal Neoplasms | 3 | 2024 | 50 | 0.550 |
Why?
| Pinealoma | 1 | 2015 | 5 | 0.540 |
Why?
| PAX2 Transcription Factor | 3 | 2010 | 22 | 0.510 |
Why?
| Glioma | 4 | 2019 | 79 | 0.480 |
Why?
| Male | 33 | 2024 | 27350 | 0.470 |
Why?
| Ataxia | 2 | 2015 | 22 | 0.470 |
Why?
| Diagnosis, Differential | 10 | 2020 | 1133 | 0.450 |
Why?
| Central Nervous System Neoplasms | 2 | 2023 | 57 | 0.440 |
Why?
| Chordoma | 2 | 2010 | 10 | 0.420 |
Why?
| Meningioma | 3 | 2024 | 43 | 0.400 |
Why?
| Encephalitis | 3 | 2016 | 48 | 0.370 |
Why?
| Fatal Outcome | 4 | 2020 | 225 | 0.370 |
Why?
| Hematologic Neoplasms | 2 | 2023 | 99 | 0.370 |
Why?
| Adult | 22 | 2024 | 14196 | 0.370 |
Why?
| Female | 31 | 2024 | 28437 | 0.370 |
Why?
| Aged | 13 | 2024 | 10059 | 0.360 |
Why?
| Craniopharyngioma | 1 | 2009 | 9 | 0.350 |
Why?
| Neurofibromatosis 1 | 2 | 2019 | 28 | 0.340 |
Why?
| Neoplasm Metastasis | 4 | 2019 | 252 | 0.340 |
Why?
| Fragile X Syndrome | 1 | 2008 | 7 | 0.330 |
Why?
| Neuroectodermal Tumors, Primitive | 1 | 2008 | 4 | 0.330 |
Why?
| Peripheral Nervous System | 1 | 2008 | 18 | 0.330 |
Why?
| Chondrosarcoma | 1 | 2007 | 13 | 0.320 |
Why?
| Middle Aged | 21 | 2024 | 13094 | 0.320 |
Why?
| Mutation | 5 | 2020 | 1499 | 0.320 |
Why?
| Skull Base Neoplasms | 1 | 2007 | 23 | 0.320 |
Why?
| Prenatal Diagnosis | 1 | 2008 | 108 | 0.300 |
Why?
| Mitogen-Activated Protein Kinases | 2 | 2008 | 168 | 0.300 |
Why?
| Radiotherapy | 2 | 2020 | 144 | 0.300 |
Why?
| Melanoma | 3 | 2020 | 315 | 0.290 |
Why?
| Neoplasms | 2 | 2015 | 1309 | 0.290 |
Why?
| Liver Neoplasms | 3 | 2005 | 353 | 0.290 |
Why?
| In Situ Hybridization, Fluorescence | 3 | 2024 | 277 | 0.290 |
Why?
| Adenoma, Oxyphilic | 1 | 2006 | 16 | 0.290 |
Why?
| Syndecan-1 | 1 | 2006 | 82 | 0.290 |
Why?
| Young Adult | 10 | 2024 | 4320 | 0.280 |
Why?
| Proto-Oncogene Proteins c-kit | 1 | 2005 | 35 | 0.270 |
Why?
| Neurosurgical Procedures | 3 | 2015 | 120 | 0.270 |
Why?
| Child | 12 | 2024 | 7312 | 0.260 |
Why?
| Magnetic Resonance Imaging | 7 | 2020 | 1603 | 0.250 |
Why?
| Skin Neoplasms | 3 | 2020 | 530 | 0.250 |
Why?
| Histiocytoma, Malignant Fibrous | 1 | 2024 | 1 | 0.250 |
Why?
| Tissue Banks | 1 | 2024 | 8 | 0.250 |
Why?
| Lymphoma, B-Cell, Marginal Zone | 1 | 2023 | 22 | 0.230 |
Why?
| Nerve Sheath Neoplasms | 2 | 2015 | 23 | 0.220 |
Why?
| Adolescent | 11 | 2024 | 6890 | 0.220 |
Why?
| Neoplasms, Neuroepithelial | 1 | 2022 | 3 | 0.220 |
Why?
| Ki-67 Antigen | 2 | 2020 | 63 | 0.220 |
Why?
| Histiocytic Sarcoma | 1 | 2022 | 2 | 0.220 |
Why?
| Neural Stem Cells | 1 | 2022 | 27 | 0.210 |
Why?
| STAT2 Transcription Factor | 1 | 2021 | 7 | 0.210 |
Why?
| Sensitivity and Specificity | 5 | 2010 | 925 | 0.210 |
Why?
| STAT1 Transcription Factor | 1 | 2021 | 27 | 0.210 |
Why?
| Li-Fraumeni Syndrome | 1 | 2021 | 13 | 0.210 |
Why?
| Sella Turcica | 1 | 2021 | 7 | 0.200 |
Why?
| Treatment Outcome | 5 | 2020 | 5596 | 0.200 |
Why?
| Amyloid | 1 | 2020 | 29 | 0.190 |
Why?
| Turkey | 1 | 2020 | 17 | 0.190 |
Why?
| Myopathies, Structural, Congenital | 1 | 2020 | 11 | 0.190 |
Why?
| Neoplasm Grading | 1 | 2020 | 131 | 0.190 |
Why?
| Drug Therapy | 1 | 2020 | 49 | 0.190 |
Why?
| Epidural Neoplasms | 1 | 2019 | 5 | 0.180 |
Why?
| Apoptosis Regulatory Proteins | 1 | 2020 | 96 | 0.180 |
Why?
| Spinal Cord Compression | 1 | 2019 | 10 | 0.180 |
Why?
| Phenotype | 2 | 2020 | 822 | 0.180 |
Why?
| Neurilemmoma | 1 | 2019 | 27 | 0.180 |
Why?
| Telomere Homeostasis | 1 | 2019 | 11 | 0.180 |
Why?
| Follow-Up Studies | 3 | 2020 | 2384 | 0.180 |
Why?
| Aged, 80 and over | 3 | 2020 | 3442 | 0.180 |
Why?
| Telomere | 1 | 2019 | 36 | 0.180 |
Why?
| Paranasal Sinus Neoplasms | 1 | 2019 | 27 | 0.180 |
Why?
| Adaptor Proteins, Signal Transducing | 1 | 2020 | 208 | 0.170 |
Why?
| Biopsy | 3 | 2017 | 694 | 0.170 |
Why?
| Predictive Value of Tests | 4 | 2017 | 1053 | 0.170 |
Why?
| Tomography, X-Ray Computed | 3 | 2020 | 1210 | 0.170 |
Why?
| Dopamine Antagonists | 1 | 2018 | 19 | 0.170 |
Why?
| Prognosis | 2 | 2024 | 2116 | 0.170 |
Why?
| Thiazoles | 1 | 2018 | 62 | 0.170 |
Why?
| Diffuse Cerebral Sclerosis of Schilder | 1 | 2018 | 8 | 0.170 |
Why?
| Amino Acyl-tRNA Synthetases | 1 | 2018 | 6 | 0.170 |
Why?
| Paresis | 1 | 2018 | 5 | 0.160 |
Why?
| Astrocytoma | 1 | 2018 | 22 | 0.160 |
Why?
| Meningitis, Cryptococcal | 1 | 2018 | 12 | 0.160 |
Why?
| Muscular Diseases | 1 | 2018 | 63 | 0.160 |
Why?
| Carcinoma | 1 | 2019 | 153 | 0.160 |
Why?
| Pineal Gland | 1 | 2017 | 6 | 0.160 |
Why?
| Fibrous Dysplasia of Bone | 1 | 2017 | 6 | 0.160 |
Why?
| Blindness | 1 | 2017 | 32 | 0.160 |
Why?
| Piperazines | 1 | 2018 | 117 | 0.160 |
Why?
| Status Epilepticus | 1 | 2018 | 37 | 0.160 |
Why?
| Orbit | 1 | 2017 | 35 | 0.150 |
Why?
| Molecular Diagnostic Techniques | 1 | 2017 | 40 | 0.150 |
Why?
| Optic Nerve Diseases | 1 | 2017 | 27 | 0.150 |
Why?
| Decompression, Surgical | 1 | 2017 | 52 | 0.150 |
Why?
| Diagnostic Errors | 1 | 2017 | 73 | 0.150 |
Why?
| Case-Control Studies | 1 | 2020 | 1242 | 0.150 |
Why?
| Neural Tube Defects | 1 | 2016 | 29 | 0.150 |
Why?
| Antigens, Neoplasm | 3 | 2008 | 170 | 0.150 |
Why?
| Mitochondrial Diseases | 1 | 2018 | 110 | 0.150 |
Why?
| Infant | 3 | 2018 | 3797 | 0.150 |
Why?
| Cervical Vertebrae | 1 | 2017 | 64 | 0.140 |
Why?
| Pituitary Apoplexy | 1 | 2016 | 4 | 0.140 |
Why?
| Thoracic Neoplasms | 1 | 2016 | 11 | 0.140 |
Why?
| Social Media | 1 | 2018 | 104 | 0.140 |
Why?
| Pregnancy Trimester, Second | 1 | 2016 | 28 | 0.140 |
Why?
| Hypesthesia | 1 | 2016 | 18 | 0.140 |
Why?
| Epithelioid Cells | 1 | 2015 | 15 | 0.140 |
Why?
| Astrocytes | 3 | 2008 | 140 | 0.140 |
Why?
| Intracranial Hemorrhages | 1 | 2016 | 41 | 0.140 |
Why?
| Lymphopenia | 1 | 2015 | 21 | 0.140 |
Why?
| Leukoencephalopathy, Progressive Multifocal | 1 | 2015 | 13 | 0.140 |
Why?
| Plasmacytoma | 1 | 2016 | 47 | 0.140 |
Why?
| Diplopia | 1 | 2015 | 22 | 0.140 |
Why?
| Child, Preschool | 6 | 2024 | 4132 | 0.130 |
Why?
| Pituitary Gland | 1 | 2016 | 75 | 0.130 |
Why?
| Paraproteinemias | 1 | 2016 | 79 | 0.130 |
Why?
| Brain Stem | 1 | 2015 | 44 | 0.130 |
Why?
| Immunoglobulin Light Chains | 1 | 2016 | 100 | 0.130 |
Why?
| Cytogenetic Analysis | 1 | 2015 | 89 | 0.130 |
Why?
| Epidermal Cyst | 1 | 2015 | 14 | 0.130 |
Why?
| Soft Tissue Neoplasms | 1 | 2015 | 65 | 0.130 |
Why?
| Osteonecrosis | 1 | 2015 | 36 | 0.130 |
Why?
| Spinal Cord Diseases | 1 | 2015 | 37 | 0.130 |
Why?
| Neoplasm Recurrence, Local | 3 | 2022 | 643 | 0.120 |
Why?
| CD4-Positive T-Lymphocytes | 1 | 2015 | 180 | 0.120 |
Why?
| Seizures | 1 | 2016 | 207 | 0.120 |
Why?
| DNA-Binding Proteins | 2 | 2010 | 463 | 0.120 |
Why?
| HIV Infections | 1 | 2018 | 394 | 0.120 |
Why?
| Cystadenocarcinoma, Serous | 2 | 2004 | 74 | 0.110 |
Why?
| Combined Modality Therapy | 1 | 2015 | 694 | 0.110 |
Why?
| Balamuthia mandrillaris | 1 | 2012 | 2 | 0.110 |
Why?
| Amebiasis | 1 | 2012 | 6 | 0.110 |
Why?
| Receptor, erbB-2 | 2 | 2003 | 79 | 0.110 |
Why?
| Neoplasms, Radiation-Induced | 1 | 2012 | 42 | 0.110 |
Why?
| Granuloma | 1 | 2012 | 46 | 0.110 |
Why?
| Neurons | 2 | 2008 | 483 | 0.110 |
Why?
| Biopsy, Fine-Needle | 3 | 2015 | 116 | 0.100 |
Why?
| Pregnancy Complications | 1 | 2016 | 387 | 0.100 |
Why?
| Multiple Myeloma | 2 | 2023 | 3024 | 0.100 |
Why?
| Chromosomal Proteins, Non-Histone | 1 | 2010 | 44 | 0.100 |
Why?
| Chromosome Aberrations | 1 | 2012 | 315 | 0.100 |
Why?
| Spinal Neoplasms | 1 | 2010 | 32 | 0.090 |
Why?
| Antibodies, Monoclonal | 3 | 2003 | 560 | 0.090 |
Why?
| Uterine Cervical Neoplasms | 2 | 2003 | 276 | 0.090 |
Why?
| Cranial Nerve Neoplasms | 1 | 2009 | 6 | 0.090 |
Why?
| Gene Deletion | 1 | 2010 | 296 | 0.090 |
Why?
| Neoplasms, Multiple Primary | 1 | 2009 | 45 | 0.090 |
Why?
| Ganglia, Autonomic | 1 | 2008 | 5 | 0.080 |
Why?
| beta Catenin | 1 | 2009 | 102 | 0.080 |
Why?
| Myelin Sheath | 1 | 2008 | 28 | 0.080 |
Why?
| Transcriptome | 2 | 2021 | 347 | 0.080 |
Why?
| Fetal Death | 1 | 2008 | 22 | 0.080 |
Why?
| Spinal Cord | 1 | 2008 | 150 | 0.080 |
Why?
| Disease Progression | 2 | 2020 | 915 | 0.070 |
Why?
| Transcription Factors | 1 | 2010 | 619 | 0.070 |
Why?
| Lung Neoplasms | 2 | 2003 | 631 | 0.070 |
Why?
| Glial Fibrillary Acidic Protein | 2 | 2003 | 37 | 0.070 |
Why?
| Gestational Age | 1 | 2008 | 431 | 0.070 |
Why?
| Cytoplasm | 2 | 2004 | 106 | 0.070 |
Why?
| Ultrasonography, Prenatal | 1 | 2008 | 177 | 0.070 |
Why?
| Biopsy, Needle | 2 | 2004 | 195 | 0.070 |
Why?
| Gastrointestinal Stromal Tumors | 1 | 2005 | 21 | 0.070 |
Why?
| Pregnancy | 2 | 2016 | 2614 | 0.070 |
Why?
| Carcinoma, Neuroendocrine | 1 | 2005 | 27 | 0.070 |
Why?
| Orbital Neoplasms | 1 | 2005 | 30 | 0.070 |
Why?
| Carcinoma, Small Cell | 1 | 2004 | 28 | 0.060 |
Why?
| Down-Regulation | 1 | 2006 | 392 | 0.060 |
Why?
| Retrospective Studies | 3 | 2018 | 6387 | 0.060 |
Why?
| Serine Endopeptidases | 1 | 2004 | 57 | 0.060 |
Why?
| Lymphoma, Non-Hodgkin | 1 | 2004 | 63 | 0.060 |
Why?
| Oncogene Proteins, Fusion | 1 | 2024 | 60 | 0.060 |
Why?
| Acetic Acid | 1 | 2003 | 12 | 0.060 |
Why?
| Cell Nucleus | 3 | 2010 | 205 | 0.060 |
Why?
| Acetates | 1 | 2003 | 48 | 0.060 |
Why?
| Oligonucleotide Array Sequence Analysis | 1 | 2004 | 473 | 0.060 |
Why?
| Ovarian Neoplasms | 2 | 2004 | 471 | 0.060 |
Why?
| Ischemic Attack, Transient | 1 | 2003 | 58 | 0.050 |
Why?
| X Chromosome Inactivation | 1 | 2022 | 4 | 0.050 |
Why?
| Cystadenocarcinoma, Papillary | 1 | 2002 | 15 | 0.050 |
Why?
| Mouth Neoplasms | 1 | 2002 | 25 | 0.050 |
Why?
| Cranial Fossa, Posterior | 1 | 2022 | 8 | 0.050 |
Why?
| Salivary Gland Neoplasms | 1 | 2002 | 24 | 0.050 |
Why?
| Lymph Nodes | 1 | 2004 | 282 | 0.050 |
Why?
| Neuroglia | 1 | 2022 | 51 | 0.050 |
Why?
| Janus Kinase 1 | 1 | 2021 | 20 | 0.050 |
Why?
| Cell Lineage | 1 | 2022 | 94 | 0.050 |
Why?
| Janus Kinase 2 | 1 | 2021 | 31 | 0.050 |
Why?
| Oncogene Proteins, Viral | 1 | 2002 | 57 | 0.050 |
Why?
| Uterine Neoplasms | 1 | 2002 | 63 | 0.050 |
Why?
| Germ-Line Mutation | 1 | 2021 | 68 | 0.050 |
Why?
| Organoids | 1 | 2021 | 41 | 0.050 |
Why?
| Prostatic Neoplasms | 1 | 2005 | 411 | 0.050 |
Why?
| Nitriles | 1 | 2021 | 71 | 0.050 |
Why?
| Dendritic Cells | 1 | 2002 | 142 | 0.050 |
Why?
| Motor Activity | 1 | 2003 | 248 | 0.050 |
Why?
| Bone Neoplasms | 1 | 2003 | 191 | 0.050 |
Why?
| Gene Expression Regulation, Neoplastic | 2 | 2021 | 867 | 0.050 |
Why?
| Pyrazoles | 1 | 2021 | 112 | 0.050 |
Why?
| Hippocampus | 1 | 2003 | 240 | 0.050 |
Why?
| Neoplasm Staging | 2 | 2019 | 801 | 0.050 |
Why?
| Pyrimidines | 1 | 2021 | 196 | 0.050 |
Why?
| Neurofibrosarcoma | 1 | 2019 | 1 | 0.050 |
Why?
| Immunotherapy | 1 | 2002 | 260 | 0.050 |
Why?
| Neurofibromin 1 | 1 | 2019 | 14 | 0.050 |
Why?
| Meningeal Carcinomatosis | 1 | 2019 | 6 | 0.050 |
Why?
| Sarcoma, Myeloid | 1 | 2019 | 22 | 0.040 |
Why?
| Immunophenotyping | 1 | 2019 | 117 | 0.040 |
Why?
| Gene Expression Profiling | 1 | 2004 | 1138 | 0.040 |
Why?
| Tourette Syndrome | 1 | 2018 | 10 | 0.040 |
Why?
| Creatine Kinase | 1 | 2018 | 35 | 0.040 |
Why?
| Obsessive-Compulsive Disorder | 1 | 2018 | 42 | 0.040 |
Why?
| Geography | 1 | 2018 | 81 | 0.040 |
Why?
| Kaplan-Meier Estimate | 1 | 2019 | 514 | 0.040 |
Why?
| Adenocarcinoma | 1 | 2002 | 428 | 0.040 |
Why?
| High-Throughput Nucleotide Sequencing | 1 | 2019 | 206 | 0.040 |
Why?
| Information Dissemination | 1 | 2018 | 103 | 0.040 |
Why?
| Muscle Fibers, Skeletal | 1 | 2018 | 77 | 0.040 |
Why?
| Cardiomyopathy, Restrictive | 1 | 2016 | 5 | 0.040 |
Why?
| Polymorphism, Single Nucleotide | 1 | 2019 | 558 | 0.040 |
Why?
| Electroencephalography | 1 | 2018 | 353 | 0.040 |
Why?
| Optic Nerve | 1 | 2016 | 46 | 0.030 |
Why?
| Headache | 1 | 2016 | 78 | 0.030 |
Why?
| Hematoma | 1 | 2016 | 60 | 0.030 |
Why?
| Internet | 1 | 2018 | 274 | 0.030 |
Why?
| Vision Disorders | 1 | 2016 | 71 | 0.030 |
Why?
| Microsurgery | 1 | 2015 | 35 | 0.030 |
Why?
| Visual Acuity | 1 | 2016 | 143 | 0.030 |
Why?
| Recurrence | 1 | 2016 | 692 | 0.030 |
Why?
| Magnetic Resonance Spectroscopy | 1 | 2015 | 252 | 0.030 |
Why?
| Endoscopy | 1 | 2015 | 131 | 0.030 |
Why?
| Glucocorticoids | 1 | 2015 | 276 | 0.030 |
Why?
| Interleukin-2 | 2 | 2003 | 75 | 0.030 |
Why?
| Chromosomes, Human, Pair 12 | 1 | 2012 | 15 | 0.030 |
Why?
| Chromosomes, Human, Pair 22 | 1 | 2012 | 43 | 0.030 |
Why?
| Rats, Wistar | 2 | 2003 | 243 | 0.030 |
Why?
| Muscle, Skeletal | 1 | 2018 | 843 | 0.030 |
Why?
| Steroids | 1 | 2012 | 55 | 0.030 |
Why?
| Neurologic Examination | 1 | 2012 | 76 | 0.030 |
Why?
| Medical Records | 1 | 2012 | 92 | 0.030 |
Why?
| Tumor Cells, Cultured | 2 | 2003 | 483 | 0.030 |
Why?
| Chromosomes, Human, Pair 1 | 1 | 2012 | 113 | 0.030 |
Why?
| Inflammation | 1 | 2016 | 677 | 0.020 |
Why?
| Age Factors | 1 | 2015 | 1198 | 0.020 |
Why?
| Antibodies, Monoclonal, Humanized | 2 | 2003 | 239 | 0.020 |
Why?
| Polymerase Chain Reaction | 1 | 2012 | 533 | 0.020 |
Why?
| Flow Cytometry | 2 | 2003 | 548 | 0.020 |
Why?
| Neoplasm Invasiveness | 1 | 2010 | 294 | 0.020 |
Why?
| Cell Differentiation | 1 | 2010 | 717 | 0.020 |
Why?
| Cell Membrane | 1 | 2008 | 279 | 0.020 |
Why?
| Anti-Bacterial Agents | 1 | 2012 | 816 | 0.020 |
Why?
| Rats | 2 | 2003 | 3435 | 0.020 |
Why?
| Synaptophysin | 1 | 2005 | 9 | 0.020 |
Why?
| Neoplasms, Hormone-Dependent | 1 | 2005 | 8 | 0.020 |
Why?
| Receptors, Vascular Endothelial Growth Factor | 1 | 2005 | 25 | 0.020 |
Why?
| Kidney | 1 | 2010 | 828 | 0.020 |
Why?
| Epithelium | 1 | 2004 | 70 | 0.020 |
Why?
| Cytodiagnosis | 1 | 2004 | 42 | 0.020 |
Why?
| Vascular Endothelial Growth Factor A | 1 | 2005 | 231 | 0.020 |
Why?
| Ovary | 1 | 2004 | 104 | 0.020 |
Why?
| MART-1 Antigen | 1 | 2004 | 12 | 0.020 |
Why?
| Eye Neoplasms | 1 | 2004 | 10 | 0.020 |
Why?
| Antibody-Dependent Cell Cytotoxicity | 1 | 2003 | 15 | 0.020 |
Why?
| Tumor Stem Cell Assay | 1 | 2003 | 21 | 0.020 |
Why?
| Lymphatic Metastasis | 1 | 2004 | 253 | 0.010 |
Why?
| Superior Colliculi | 1 | 2003 | 6 | 0.010 |
Why?
| Antimetabolites | 1 | 2003 | 12 | 0.010 |
Why?
| Lectins | 1 | 2003 | 18 | 0.010 |
Why?
| Regression Analysis | 1 | 2004 | 446 | 0.010 |
Why?
| Fibroblast Growth Factor 2 | 1 | 2003 | 32 | 0.010 |
Why?
| Microinjections | 1 | 2003 | 31 | 0.010 |
Why?
| Deoxyglucose | 1 | 2003 | 27 | 0.010 |
Why?
| Endothelium | 1 | 2003 | 45 | 0.010 |
Why?
| Carbon Radioisotopes | 1 | 2003 | 46 | 0.010 |
Why?
| Coloring Agents | 1 | 2003 | 84 | 0.010 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2004 | 682 | 0.010 |
Why?
| Cell Count | 1 | 2003 | 181 | 0.010 |
Why?
| Multivariate Analysis | 1 | 2004 | 646 | 0.010 |
Why?
| Foreign Bodies | 1 | 2003 | 64 | 0.010 |
Why?
| Tumor Virus Infections | 1 | 2002 | 43 | 0.010 |
Why?
| Hepatocytes | 1 | 2004 | 216 | 0.010 |
Why?
| Antibodies, Monoclonal, Murine-Derived | 1 | 2002 | 55 | 0.010 |
Why?
| Conditioning, Operant | 1 | 2003 | 106 | 0.010 |
Why?
| Papillomaviridae | 1 | 2002 | 107 | 0.010 |
Why?
| Microglia | 1 | 2003 | 136 | 0.010 |
Why?
| Killer Cells, Natural | 1 | 2002 | 107 | 0.010 |
Why?
| Cell Division | 1 | 2002 | 330 | 0.010 |
Why?
| Neoplasm Proteins | 1 | 2004 | 367 | 0.010 |
Why?
| Learning | 1 | 2003 | 171 | 0.010 |
Why?
| Cognition Disorders | 1 | 2003 | 240 | 0.010 |
Why?
| RNA, Messenger | 1 | 2004 | 1222 | 0.010 |
Why?
| Cells, Cultured | 1 | 2004 | 1755 | 0.010 |
Why?
| Papillomavirus Infections | 1 | 2002 | 163 | 0.010 |
Why?
| Macrophages | 1 | 2003 | 401 | 0.010 |
Why?
| Reproducibility of Results | 1 | 2004 | 1307 | 0.010 |
Why?
| Animals | 2 | 2003 | 14435 | 0.010 |
Why?
| Antineoplastic Agents | 1 | 2002 | 1295 | 0.010 |
Why?
| Breast Neoplasms | 1 | 2002 | 1248 | 0.010 |
Why?
|
|
Gokden's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|